[Session 4] JAGntd-GHIT NTD webinar series: Challenges of expanding access to health products in the fight against NTDs
Neglected tropical diseases (NTDs) prevail among the hard-to-reach populations in the world. To protect them from NTDs, developing good health products is necessary, but is not sufficient without creating access to them. Access is a complex matter: no single organization can create it successfully. This webinar series will clarify some conceptual aspects about access, discuss key access challenges from different perspectives and how these can be overcome. The webinar series also considers how Japanese actors might be able to contribute to addressing some of those access challenges.
[Language] English. Simultaneous translation into Japanese will be provided.
[Organizer] Japan Alliance on Global Neglected Tropical Diseases (JAGntd)
[Sponsor] GHIT Fund
Session 4: WHO/ESPEN’s perspective: Strengthening national NTD programs in Africa
Session 4 looks into the WHO’s regional project to sweep five NTDs out of Africa, called Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN). Working with African countries, ESPEN has contributed to mobilizing political, technical and financial resources to accelerate mass drug administration of donated medicines. From the WHO’s perspective, the speaker will discuss what kinds of assistance have been needed by African countries in order to deliver those medicines. The audience will find the importance of external assistance to distribute medicines among developing countries.
[Date/Time] Thursday, December 16, 2021 17: 00-18: 00 (Japan time)
[Speaker] Modeste Tezembong: Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN), WHO/AFRO
Session 5: "Nudging the Industry (1): Visualizing Pharmaceutical Companies' Efforts" January 2022
Session 6: "Nudging the Industry (2): Patent as a Barrier or Leverage?" February 2022
Session 7: "Financing: Who Pays for What?" March 2022
Replay past webinars on the JAGntd Youtube channel.
Session 1: "Concepts and definitions: What is access?"
Session 2: "Developer’s perspective: Fexinidazole for African Trypanosomiasis"
Session 3: "Country's Perspective: Introduction of Pediatric Praziquantel for Schistosomiasis in Tanzania"